Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-06 03:17 | 2021-10-01 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | OPT+S | $261.70 | 5,300 | $1,387,008 | 32,637 | -14.0% |
| 2021-09-04 03:26 | 2021-09-01 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | OPT+S | $271.81 | 5,300 | $1,440,616 | 32,637 | -14.0% |
| 2021-08-13 03:03 | 2021-08-10 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | OPT+S | $265.95 | 5,300 | $1,409,523 | 32,637 | -14.0% |
| 2020-07-22 04:42 | 2020-07-17 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | OPT+S | $197.61 | 9,675 | $1,911,917 | 12,332 | -44.0% |
| 2020-07-16 03:53 | 2020-07-13 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | OPT+S | $195.00 | 200 | $39,000 | 12,332 | -1.6% |
| 2020-02-14 04:41 | 2020-02-11 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | OPT+S | $185.25 | 5,000 | $926,250 | 12,332 | -28.8% |
| 2020-02-04 04:22 | 2020-01-30 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | OPT+S | $176.01 | 10,000 | $1,760,108 | 12,332 | -44.8% |
| 2019-11-13 03:54 | 2019-11-07 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $170.32 | 5,000 | $851,602 | 104,807 | -4.6% |
| 2019-11-01 03:31 | 2019-10-29 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $160.13 | 5,000 | $800,650 | 109,807 | -4.4% |
| 2019-09-18 02:19 | 2019-09-13 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $150.02 | 5,000 | $750,100 | 114,807 | -4.2% |
| 2019-08-22 03:30 | 2019-08-19 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $144.66 | 5,000 | $723,318 | 119,807 | -4.0% |
| 2018-05-11 02:08 | 2018-05-09 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $150.38 | 6,000 | $902,252 | 132,319 | -4.3% |
| 2018-05-09 02:23 | 2018-05-04 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $135.05 | 6,000 | $810,273 | 138,319 | -4.2% |
| 2018-03-19 23:39 | 2018-03-15 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $125.02 | 6,000 | $750,120 | 144,319 | -4.0% |
| 2018-03-08 04:38 | 2018-03-05 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $115.01 | 3,727 | $428,633 | 150,319 | -2.4% |
| 2018-03-03 03:02 | 2018-02-28 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $115.00 | 2,273 | $261,395 | 154,046 | -1.5% |
| 2018-01-19 01:49 | 2018-01-16 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $90.99 | 6,000 | $545,954 | 159,319 | -3.6% |
| 2017-02-15 02:44 | 2017-02-14 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $75.00 | 6,000 | $450,000 | 174,307 | -3.3% |
| 2017-02-11 03:21 | 2017-02-08 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $70.20 | 2,700 | $189,551 | 180,307 | -1.5% |
| 2017-02-07 04:56 | 2017-02-02 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $70.41 | 2,886 | $203,207 | 183,007 | -1.6% |
| 2017-02-02 03:59 | 2017-01-30 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $70.99 | 4,414 | $313,355 | 185,893 | -2.3% |
| 2017-01-28 04:31 | 2017-01-25 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $74.24 | 7,000 | $519,688 | 190,307 | -3.5% |
| 2016-09-07 04:23 | 2016-09-01 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $70.22 | 6,099 | $428,289 | 197,307 | -3.0% |
| 2016-09-01 04:34 | 2016-08-29 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $71.17 | 5,300 | $377,214 | 203,406 | -2.5% |
| 2016-08-30 03:48 | 2016-08-25 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $71.02 | 5,300 | $376,403 | 208,706 | -2.5% |
| 2016-08-25 04:26 | 2016-08-22 | PEN | Penumbra Inc | Rothman Lynn | Officer; EVP and Chief Business Officer | Surgical & Medical Instruments & Apparatus | SALE | $72.99 | 6,300 | $459,806 | 214,006 | -2.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.